Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
2.350
-0.010 (-0.42%)
Nov 4, 2024, 4:00 PM EST - Market closed
Armata Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Cash & Equivalents | 26.41 | 13.52 | 14.85 | 10.29 | 9.65 | 6.03 | Upgrade
|
| Cash & Short-Term Investments | 26.41 | 13.52 | 14.85 | 10.29 | 9.65 | 6.03 | Upgrade
|
| Cash Growth | 111.99% | -8.95% | 44.36% | 6.62% | 59.94% | -37.57% | Upgrade
|
| Other Receivables | 1.24 | 3.36 | 8.53 | 2.99 | 0.56 | - | Upgrade
|
| Receivables | 1.24 | 3.36 | 8.53 | 2.99 | 0.56 | - | Upgrade
|
| Prepaid Expenses | 3.26 | 2.27 | 3.66 | 1.72 | 0.64 | 0.62 | Upgrade
|
| Total Current Assets | 30.9 | 19.15 | 27.05 | 15 | 10.85 | 6.66 | Upgrade
|
| Property, Plant & Equipment | 57.15 | 57.28 | 46.65 | 38.07 | 12.84 | 4.22 | Upgrade
|
| Goodwill | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | 3.49 | Upgrade
|
| Long-Term Deferred Charges | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | 10.26 | Upgrade
|
| Other Long-Term Assets | 6.52 | 8.19 | 8.39 | 2.96 | 2.09 | 0.84 | Upgrade
|
| Total Assets | 108.31 | 98.36 | 95.83 | 69.77 | 39.52 | 25.45 | Upgrade
|
| Accounts Payable | 1.74 | 1.59 | 1.68 | 1.14 | 0.96 | 0.55 | Upgrade
|
| Accrued Expenses | 3.33 | 4.87 | 6.18 | 2.17 | 1.54 | 2.05 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.72 | - | Upgrade
|
| Current Portion of Leases | 6.6 | 9.48 | 17.01 | 1.51 | 1.55 | 1.31 | Upgrade
|
| Other Current Liabilities | 0.12 | 0.52 | - | - | 1.94 | 0.97 | Upgrade
|
| Total Current Liabilities | 123.18 | 16.46 | 24.87 | 4.81 | 6.71 | 4.88 | Upgrade
|
| Long-Term Debt | - | 82.31 | - | - | - | - | Upgrade
|
| Long-Term Leases | 28.16 | 28.58 | 31.8 | 36.48 | 10.88 | 1.56 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | 3.08 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 1.35 | Upgrade
|
| Total Liabilities | 154.41 | 130.43 | 59.75 | 44.37 | 20.66 | 10.86 | Upgrade
|
| Common Stock | 0.36 | 0.36 | 0.36 | 0.27 | 0.19 | 0.1 | Upgrade
|
| Additional Paid-In Capital | 278.39 | 276.39 | 275.49 | 227.98 | 198.37 | 172.02 | Upgrade
|
| Retained Earnings | -324.85 | -308.82 | -239.77 | -202.86 | -179.7 | -157.52 | Upgrade
|
| Shareholders' Equity | -46.1 | -32.07 | 36.08 | 25.4 | 18.86 | 14.59 | Upgrade
|
| Total Liabilities & Equity | 108.31 | 98.36 | 95.83 | 69.77 | 39.52 | 25.45 | Upgrade
|
| Total Debt | 146.14 | 120.37 | 48.82 | 37.99 | 13.15 | 2.86 | Upgrade
|
| Net Cash (Debt) | -119.74 | -106.85 | -33.96 | -27.7 | -3.5 | 3.17 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | -67.19% | Upgrade
|
| Net Cash Per Share | -3.32 | -2.96 | -0.99 | -1.15 | -0.21 | 0.40 | Upgrade
|
| Filing Date Shares Outstanding | 36.18 | 36.15 | 36.14 | 30.73 | 24.94 | 10.93 | Upgrade
|
| Total Common Shares Outstanding | 36.16 | 36.12 | 36.14 | 27.11 | 18.69 | 9.92 | Upgrade
|
| Working Capital | -92.28 | 2.69 | 2.17 | 10.18 | 4.14 | 1.78 | Upgrade
|
| Book Value Per Share | -1.28 | -0.89 | 1.00 | 0.94 | 1.01 | 1.47 | Upgrade
|
| Tangible Book Value | -49.59 | -35.56 | 32.59 | 21.91 | 15.37 | 11.1 | Upgrade
|
| Tangible Book Value Per Share | -1.37 | -0.98 | 0.90 | 0.81 | 0.82 | 1.12 | Upgrade
|
| Machinery | 22.48 | 20.93 | 11.27 | 9.02 | 7.68 | 7.02 | Upgrade
|
| Leasehold Improvements | 3.45 | 3.45 | 3.45 | 3.42 | 3.42 | 3.33 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.